Glycogen storage disease type II: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (17 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For the main page on glycogen storage disease, please click [[Glycogen storage disease|here]]'''<br> | |||
'''For patient information click [[Glycogen storage disease type II (patient information)|here]]''' | |||
{{Glycogen storage disease type II}} | {{Glycogen storage disease type II}} | ||
{{CMG}} | {{CMG}}; {{AE}}{{Anmol}} | ||
{{SK}} Glycogen storage disease type | {{SK}} Glycogen storage disease type 2; Pompe disease; acid maltase deficiency; glycogenosis type 2; alpha-1, 4-glucosidase deficiency; GSD II; GSD type 2; acid alpha-glucosidase deficiency; GAA deficiency; Generalized cardiac form glycogenosis; Cardiomegalia glycogenica diffusa. | ||
==[[Glycogen storage disease type II overview|Overview]]== | ==[[Glycogen storage disease type II overview|Overview]]== | ||
==[[Glycogen storage disease type II historical perspective|Historical Perspective]]== | ==[[Glycogen storage disease type II historical perspective|Historical Perspective]]== | ||
==[[Glycogen storage disease type II classification|Classification]]== | ==[[Glycogen storage disease type II classification|Classification]]== | ||
==[[Glycogen storage disease type II pathophysiology |Pathophysiology]]== | ==[[Glycogen storage disease type II pathophysiology |Pathophysiology]]== | ||
==[[Glycogen storage disease type II causes|Causes]]== | ==[[Glycogen storage disease type II causes|Causes]]== | ||
==[[Glycogen storage disease type II differential diagnosis|Differentiating Glycogen storage disease type | |||
==[[Glycogen storage disease type II differential diagnosis|Differentiating Glycogen storage disease type II from other Diseases]]== | |||
==[[Glycogen storage disease type II epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Glycogen storage disease type II epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Glycogen storage disease type II natural history, complications and prognosis|Natural | |||
==[[Glycogen storage disease type II risk factors|Risk Factors]]== | |||
==[[Glycogen storage disease type II screening|Screening]]== | |||
==[[Glycogen storage disease type II natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | ==Diagnosis== | ||
[[Glycogen storage disease type II history and symptoms|History and Symptoms]] | [[Glycogen storage disease type II physical examination|Physical Examination]] | [[Glycogen storage disease type II laboratory findings|Laboratory Findings]] | [[Glycogen storage disease type II electrocardiogram|Electrocardiogram]] | [[Glycogen storage disease type II echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Glycogen storage disease type II other diagnostic studies|Other Diagnostic Studies]] | [[Glycogen storage disease type II diagnostic study of choice|Diagnostic study of Choice]] | [[Glycogen storage disease type II history and symptoms|History and Symptoms]] | [[Glycogen storage disease type II physical examination|Physical Examination]] | [[Glycogen storage disease type II laboratory findings|Laboratory Findings]] | [[Glycogen storage disease type II electrocardiogram|Electrocardiogram]] | [[Glycogen storage disease type II x ray|X Ray]] | [[Glycogen storage disease type II CT|CT]] | [[Glycogen storage disease type II MRI|MRI]] | [[Glycogen storage disease type II echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Glycogen storage disease type II other imaging findings|Other Imaging Findings]] | [[Glycogen storage disease type II other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Glycogen storage disease type II medical therapy|Medical Therapy]] | [[Glycogen storage disease type II cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Glycogen storage disease type II future or investigational therapies|Future or Investigational Therapies]] | [[Glycogen storage disease type II medical therapy|Medical Therapy]] | [[Glycogen storage disease type II surgery|Surgery]] | [[Glycogen storage disease type II primary prevention|Primary Prevention]] | [[Glycogen storage disease type II secondary prevention|Secondary Prevention]] | [[Glycogen storage disease type II cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Glycogen storage disease type II future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Glycogen storage disease type II case study one|Case #1]] | |||
[[fr:Maladie de Pompe]] | [[fr:Maladie de Pompe]] | ||
| Line 45: | Line 43: | ||
[[de:Morbus Pompe]] | [[de:Morbus Pompe]] | ||
[[es:Enfermedad de Pompe]] | [[es:Enfermedad de Pompe]] | ||
[[Category:Endocrinology]] | |||
[[Category:Hepatology]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Endocrinology]] | |||
[[Category:Hepatology]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Metabolic disorders]] | |||
Latest revision as of 19:58, 4 April 2018
For the main page on glycogen storage disease, please click here
For patient information click here
|
Glycogen storage disease type II Microchapters |
|
Differentiating Glycogen storage disease type II from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type II On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type II |
|
Directions to Hospitals Treating Glycogen storage disease type II |
|
Risk calculators and risk factors for Glycogen storage disease type II |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Synonyms and keywords: Glycogen storage disease type 2; Pompe disease; acid maltase deficiency; glycogenosis type 2; alpha-1, 4-glucosidase deficiency; GSD II; GSD type 2; acid alpha-glucosidase deficiency; GAA deficiency; Generalized cardiac form glycogenosis; Cardiomegalia glycogenica diffusa.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Glycogen storage disease type II from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Case #1 it:morbo di Pompe de:Morbus Pompe